- トップ
- 研究業績
- Iriyama N, Fujisawa S, Yoshida C, Wakita H, Chiba S, Okamoto S, Kawakami K, Takezako N, Kumagai T, Inokuchi K, Ohyashiki K, Taguchi J, Yano S, Igarashi T, Kouzai Y, Morita S, Sakamoto J, Sakamaki H. Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: Results of the D-First study. Am J Hematol 90(9):819-824, Sep, 2015 (doi: 10.1002/ajh.24096) Epub Jun 23, 2015
Iriyama N, Fujisawa S, Yoshida C, Wakita H, Chiba S, Okamoto S, Kawakami K, Takezako N, Kumagai T, Inokuchi K, Ohyashiki K, Taguchi J, Yano S, Igarashi T, Kouzai Y, Morita S, Sakamoto J, Sakamaki H. Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: Results of the D-First study. Am J Hematol 90(9):819-824, Sep, 2015 (doi: 10.1002/ajh.24096) Epub Jun 23, 2015
2015/11/25
- 研究業績
- Iriyama N, Fujisawa S, Yoshida C, Wakita H, Chiba S, Okamoto S, Kawakami K, Takezako N, Kumagai T, Inokuchi K, Ohyashiki K, Taguchi J, Yano S, Igarashi T, Kouzai Y, Morita S, Sakamoto J, Sakamaki H. Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: Results of the D-First study. Am J Hematol 90(9):819-824, Sep, 2015 (doi: 10.1002/ajh.24096) Epub Jun 23, 2015
« Truong TP, Sakata-Yanagimoto M, Yamada M, Nagae G, Enami T, Nakamot... | Chiba S, Enami T, Ogawa S, Sakata-Yanagimoto M. G17V RHOA: Genetic e... »
